Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
deals
124
×
national blog main
life sciences
startups
biotech
boston blog main
national top stories
san francisco blog main
boston top stories
new york blog main
san francisco top stories
fda
vc
wisconsin blog main
wisconsin top stories
new york top stories
san diego blog main
clinical trials
san diego top stories
seattle blog main
seattle top stories
investing
boston
health
raleigh-durham blog main
detroit blog main
healthcare
business
detroit top stories
indiana blog main
national
raleigh-durham top stories
texas blog main
boulder/denver blog main
boulder/denver top stories
cancer
indiana top stories
texas top stories
software
tech
What
medical
health
million
new
company
startup
based
bio
deal
drug
medicines
roundup
patients
raised
raises
companies
tech
cash
healthcare
help
funding
gene
technology
round
devices
platform
san
software
therapeutics
today
biotech
business
capital
developing
digital
drugs
venture
wi
acquire
announced
Language
unset
unknown
Current search:
deals
×
@xconomy.com
3 months ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 months ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 months ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 months ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 months ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
5 months ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@digitaltrends.com
6 months ago
How to watch Scrubs online: Binge the iconic medical sitcom for free
@xconomy.com
6 months ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
6 months ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
7 months ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
8 months ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
9 months ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
10 months ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
11 months ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
11 months ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
12 months ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
1 year ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
1 year ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
1 year ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
1 year ago
Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
@xconomy.com
1 year ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
1 year ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
1 year ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
1 year ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
1 year ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
1 year ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
1 year ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@engadget.com
1 year ago
Wirecutter's best deals: Save $300 on a Google Pixel 3
@xconomy.com
1 year ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
1 year ago
Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company
@xconomy.com
1 year ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
1 year ago
WI Watchlist: Microsoft, Exact Sciences, Shine & MKE Tech Hub
@xconomy.com
1 year ago
Providence St. Joseph to Buy Wisconsin Health IT Consultant Bluetree
@xconomy.com
1 year ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
1 year ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
1 year ago
Boston Tech Watch: Polaris, GE, DataRobot, Facial Recognition Woes
@xconomy.com
1 year ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
@xconomy.com
1 year ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
@xconomy.com
1 year ago
WI Watchlist: Montage, LÜM, WEDC, Titan Spine, Polco, Swallow & More
@xconomy.com
1 year ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
1 year ago
Seattle’s TransformativeMed Carves Out Niche in Medical Specialties
@xconomy.com
1 year ago
Meet the Xconomy Awards San Diego Digital Trailblazer Finalists
@xconomy.com
1 year ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
1 year ago
NorthStar Secures $75M+ as Medical Radioisotope Competition Revs Up
@xconomy.com
1 year ago
Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise
@xconomy.com
1 year ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
1 year ago
Xealth Gets $11M, Aims to Be Surescripts of Digital Health Services
@xconomy.com
1 year ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
First
Prev
Page 1
(current)
Next
Last